Image

BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders

BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders

Recruiting
18-55 years
All
Phase N/A

Powered by AI

Overview

This study aims to view variations in MRI measurements of the heart and the brain in people with anxiety versus healthy volunteers. The MRI measurements used will be Oxygenation-Sensitive Cardiac MRI (OS-CMR), a recent type of MRI which is safe, fast, and non-invasive.

Description

The investigators will prospectively analyze OS-CMR data from patients with a generalized anxiety disorder from one site. The investigators will observe how an anxiety disorder affects the OS-CMR data. In a follow-up MRI scan, the investigators will look at the OS-CMR of a subgroup who have anxiety disorder and are also undertaking cognitive behavioural therapy to asses how and if this therapy affects the OS-CMR data.

Eligibility

Inclusion Criteria:

Patient population:

Age 18-55,

  • Confirmation of an anxiety disorder as identified by the PSWQ,
  • No known, current or history, of significant medical conditions that may affect or directly involve the neurological, cardiovascular or respiratory system (except anxiety and depression)
  • Non-smoker

Healthy Volunteers:

  • Age 18-55
  • No known, current or history, of significant medical conditions that may affect or directly involve the neurological, cardiovascular or respiratory system
  • Non-smoker

Exclusion Criteria:

  • General MRI contraindications: pacemakers, defibrillating wires, implanted defibrillators, intracranial aneurysm clips, metallic foreign bodies in the eyes, pregnancy
  • History of significant neurological disease or illness that is not anxiety (e.g. Dementia, stroke)
  • Hemodynamically unstable conditions
  • Significant or uncontrolled arrhythmias
  • Severe pulmonary disease
  • Recent (<90 days) myocardial infarction
  • Recent (<90 days) surgery or coronary intervention
  • Consumption of caffeine (caffeinated beverages, coffee, tea, cocoa, chocolate) within 12h of the exam
  • Use of benzodiazepines or other short-acting anxiety medications (<1 day)

Study details
    Generalized Anxiety Disorder
    Oxygenation Sensitive CMR

NCT05574140

McGill University Health Centre/Research Institute of the McGill University Health Centre

4 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.